INTRODUCTION
Adverse drug reactions (ADRs) are a major cause of morbidity and mortality in countries having limited healthcare resources. Global incidence of ADRs in hospitalized children is 9.53%, but hospitalization due to ADRs in the elder patients is 4 times greater than younger ones as they are receiving multiple medications for long term illnesses. 1 Average incidence of ADRs from all drugs in India is 9.8%. 2 Skin is the most common organ system affected followed by Central Nervous System and Gastrointestinal Tract. 2 However, this may sound the tip of the iceberg as the ADR monitoring is still evolving in India.
Of all the Adverse Drug Reactions, antimicrobials contribute 28% which is highest compared to the other drugs. 1 Ofloxacin is an antimicrobial used for treating several bacterial infections. Ofloxacin, belonging to quinolone group of drugs, is bactericidal and acts by inhibition of bacterial DNA gyrase. Having molecular weight 361.37g/mol and molecular formula C18H20FN3O4, it is approved by FDA in January 1997 to treat pelvic inflammatory disease (PID). 3 Common side effects of ofloxacin are insomnia, nausea, vomiting, diarrhea, and headache. Incidence rate of adverse drug reactions (ADRs) to ofloxacin is 4.27%. 4 About 11% experienced the side effects of ofloxacin use in clinical trials. 5 Discontinuation of drug therapy because of side effects occurred in 4% patients. 5 Although these figures appear to be small, it is consumed for gastrointestinal infections along with ornidazole in India contributing significant burden of ADRs. However, there is no research done in past many years focusing on the adverse drug reactions of ofloxacin. This article bridges the gap of such a need.
REVIEW OF LITERATURE

Search strategy
Authors searched the pertinent studies in PubMed. First authors searched the term "ofloxacin" in the Mesh database. Out of 7 search results, the term "Ofloxacin" having meaning "a synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA replication. Articles not in English translated into English language using Google translation service. Same search strategy was utilized while searching through Copernicus database. Authors searched the Cochrane library using the term "ofloxacin" without language limit and executed advanced search between the years 1990 to 2016.
Inclusion criteria
Authors included all randomized trials, comparative studies, controlled clinical trials, observational studies, case reports with or without free full text, without language barrier in writing the review.
Exclusion criteria
Authors excluded the studies that did not show the ADRs related to ofloxacin. These included ADRs related to Levofloxacin and similar drugs. Authors excluded other studies that just assessed ofloxacin antibacterial activity
Data extraction
Authors discarded irrelevant studies after screening all titles and abstracts and evaluated the full texts of the remaining studies to determine the inclusion criteria. Authors used the standard prepared forms for data extraction.
DISCUSSION
Authors divided the ADRs related with ofloxacin into different systems like fatal, gastrointestinal, nervous system, cutaneous, musculoskeletal, hepatobiliary, cardiovascular, renal, hematological, ocular and others.
Fatal ADR
Anaphylactic shock described in a boy after taking oral ofloxacin. 
Gastrointestinal (GI) ADRs
GI disturbances such as nausea, vomiting and gastric pain were the most common ADRs followed by Central nervous system. 7 Pseudomembranous colitis associated with clostridium difficile attributed to ofloxacin treatment. 8 
Nervous system ADRs
Among the Central Nervous System adverse drug reactions, headache and insomnia were the major ones compared to the hallucinations, nightmares, confusion and depression as the minor ones. 9 However, these findings were not consistent as the post marketing surveillance in 1.5 million patient population showed that Nervous system ADRs ranked 1 st followed by hypersensitivity reaction and GI disturbances in order of frequency. 4 Sleep disturbances were common in children receiving ofloxacin treatment. 10 The rare adverse reactions like hallucination, psychosis and shock also reported in Germany in post marketing experience.
11
Generalized tonic clonic seizures prompted by ofloxacin cannot be ruled out in patient with compromised renal function secondary to drug accumulation. 12 Status epilepticus described with ofloxacin use. 13 It provoked delirium too. 14 It caused Idiopathic intracranial hypertension in a 25-year-old man treated with 400mg/day for 16 months. 15 It triggered Tourette-like syndrome in elderly patient admitted in community hospital for management of pneumonia.
Cutaneous ADRs
Angioedema developed in a 24-year-old male patient who received ofloxacin-ornidazole combination for loose motions. 17 Cutaneous vasculitis occurred in a diabetic foot infected patient, and another patient of urinary tract infection treated with ofloxacin. 18 The patient treated with ofloxacin for bronchitis and pharyngitis, got intense erythemas followed by sub-corneal pustulation associated with fever and neutrophil leukocytosis, diagnosed as toxic pustuloderma. 19 Fixed drug eruption reported with ciprofloxacin, amoxicillin, and independently as well. 20 It caused the toxic epidermal necrosis. 21 Erythema multiforme like rash ascribed to ofloxacin use. 22 A rare variant of erythema nodosum leprosum of type 2 Lepra reaction testified in ofloxacin aided multi drug therapy. 23 The type1 Lepra reaction occurred in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline. 24 It triggered Sweet's syndrome (acute febrile neutrophilic dermatosis) in a patient with Crohn's disease. 25 
Musculoskeletal ADRs
The complete rupture of Achilis tendon happened with elderly patients with concurrent administration of corticosteroid and ofloxacin. 26 Myalgia, arthralgia and multiple tendonopathy noted in 53-year-old woman exposed to ofloxacin. 27 Systematic review of observational cohort studies comparing different fluoroquinolones threw light on the relationship of tenosynovitis with ofloxacin use. 7 The marked increase in serum myoglobin and presence of urine myoglobin confirmed the association of acute rhabdomyolysis with ofloxacin.
28
Hepatobiliary ADRs
Asymptomatic hepatitis observed in resistant case of pulmonary tuberculosis, treated with the alternative therapy with Pyrazinamide and ofloxacin. 29 Moderate increase in liver enzymes noted in patient with Wegener's Granulomatosis treated with ofloxacin for the productive cough. 30 A 70-year-old man having prostatic adenoma with urinary tract infection treated with ofloxacin developed fatal sub-fulminant hepatic failure. 31 Acute severe hepatitis by ofloxacin described in 1991. 32 Sensitized lymphocytes to trimethoprim/sulfamethoxazole and ofloxacin demonstrated in patient of cholestatic hepatitis, signifying strong relationship of ofloxacin with cholestatic hepatitis.
33
Cardiovascular ADRs
Although the low rate of torsades-de-pointes reported for ofloxacin compared to other fluoroquinolones, its use in patients with prolonged QT interval cautioned. 34 Both syncope and tachycardia attributed to the cardiovascular side effects of ofloxacin induced dysarrhythmia. 34 
Renal ADRs
Acute renal failure due to ofloxacin reported in 1995. 35 It induced nephrogenic diabetes insipidus in a young patient with bilateral lobar pneumonia-acquired secondary to influenza infection. 36 
Hematologic ADRs
A 9-year-old girl reported hemoglobinuria due to ofloxacin. 37 It induced leucopenia in Malaria patient when given for acute gastroenteritis with E. coli.
38
Other ADRs
Ofloxacin inhibited the bacterial nitrite reduction. 39 It induced the photo-onycholysis in the past. 
